glucose-1,6-bisphosphate has been researched along with Glycogen Storage Disease Type V in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tarui, S | 1 |
| Kawachi, M; Kiyokawa, H; Kono, N; Kuwajima, M; Nakajima, H; Nishimura, T; Ono, A; Shimizu, T; Tarui, S; Yamada, Y | 1 |
1 review(s) available for glucose-1,6-bisphosphate and Glycogen Storage Disease Type V
| Article | Year |
|---|---|
Glycolytic defects in muscle: aspects of collaboration between basic science and clinical medicine.
Topics: Biochemical Phenomena; Biochemistry; Clinical Medicine; Fructosediphosphates; Glucose-6-Phosphate; Glucosephosphates; Glycogen; Glycogen Storage Disease; Glycogen Storage Disease Type V; Humans; Isoenzymes; Muscular Diseases; Phosphofructokinase-1; Phosphoglycerate Kinase | 1995 |
1 other study(ies) available for glucose-1,6-bisphosphate and Glycogen Storage Disease Type V
| Article | Year |
|---|---|
Low glucose-1, 6-bisphosphate and high fructose-2, 6-bisphosphate concentrations in muscles of patients with glycogenosis types VII and V.
Topics: Fructosediphosphates; Glucose-6-Phosphate; Glucosephosphates; Glycogen; Glycogen Storage Disease Type V; Glycogen Storage Disease Type VII; Glycolysis; Humans; Muscles; Reference Values | 1991 |